Qnovia (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- May 30, 2025
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $16,000,000
Company Info
- Founding Year
- 2018
- Founders
- Mario Danek
- Company Description
- Qnovia is a pharmaceutical company focused on developing and commercializing proprietary inhalation device technologies to improve patient outcomes. The company's drug delivery platform, the RespiRx™, is the first orientation-agnostic, portable vibrating mesh nebulizer that effectively operates in any position held by the patient.
- Market
- Smoking cessation and respiratory health
- Location
- Richmond, Virginia, USA
- Coinvestors
- Blue Ledge Capital, Evolution VC Partners, Vice Ventures, Gaingels